Two transaminases exist for tyrosine and phenylalanine synthesis in Bacillus subtilis. One enzyme is also responsible for the transamination of imidazole acetol phosphate to histidinol phosphate, an obligatory reaction in the synthesis of histidine. The gene involved in the synthesis of this enzyme lies in the middle of a cluster of genes, all of which are concerned with the synthesis of the aromatic amino acids. The other gene has not yet been mapped. Mutants have been isolated that lack one or the other enzyme activity. These mutants are prototrophic for tyrosine and phenylalanine. However, both classes of mutants are more sensitive than the wild-type strain to the phenylalanine analogue, fluorophenylalanine, suggesting that each of these mutants synthesizes less phenylalanine than does the wild-type strain. The two enzymes can be separated from one another by ion-exchange chromatography and glycerol-gradient centrifugation. The significance of the observation that an enzyme of histidine synthesis also plays a role in the synthesis of the aromatic amino acids is considered in light of cross-pathway regulation between the two pathways.
The gene-enzyme relationships ofthe various steps in the pathway of aromatic amino acid biosynthesis in Bacillus subtilis have in large part been elucidated (5, 13, 15) . Mutants have been isolated that are blocked in each step of the biosynthetic pathway leading to tyrosine, phenylalanine, and tryptophan and have been mapped on the B. subtilis chromosome by combining deoxyribonucleic acid (DNA) transformation and transduction by the bacteriophage PBS1 (5, 9) . One glaring omission in these data is the lack of any representative mutants blocked in the final step of tyrosine and phenylalanine synthesis. This reaction is a transamination step involving glutamate and either phydroxyphenylpyruvate, the precursor to tyrosine or phenylpyruvate, the precursor to phenylanine. Our inability to isolate such mutants was surprising in view of the fact that several hundred mutants that required tyrosine or phenylalanine individually or together were screened. The data presented in this paper indicate that we were unable to isolate such a mutant because there are two enzymes capable of transaminating tyrosine and phenylalanine. Further, they clear up one of the most intriguing features of the aro linkage group; namely, why a gene involved in histidine synthesis (hisH) is not totally out ofplace in the middle of a cluster of genes, all concerned with aromatic amino acid biosynthesis.
MATERIALS AND METHODS
Growth of cells and preparation of cell extracts. Cells for enzyme assays were routinely grown in Spizizen minimal medium (18), containing 0.5% glucose; other growth supplements were added at 20 ,ug/ ml. Cultures were grown in 200-ml volumes in 1- liter baffled flasks at 37 C on a rotary shaker. Cultures were harvested in the middle of the logarithmic phase of growth by centrifugation at 5,000 x g. The cells were washed once and then resuspended in 1.0 ml of 0.5 M potassium phosphate buffer, pH 7.5, containing 0.2 mg of phenylmethylsulfonyl fluoride per ml and 6 x 10-3 M 2-mercaptoethanol. Cells were broken by sonic disruption at 0 C with an MSE sonic oscillator set at the maximum power setting. The sonic oscillator was operated for a total of 2 temperature the optical density was determined at 330 nm for tyrosine or 320 nm for phenylalanine.
Protein concentration was determined either by the method of Lowry et al. (11) or by the method of Groves et al. (4) using bovine serum albumin as the standard.
Transformation. DNA-mediated transformation was carried out by the procedures described previously (15) .
Mutant selection. Mutants were produced and isolated by techniques previously described (10) with one slight modification. The mutagenized cells were plated on minimal medium supplemented with excess amounts of all of the amino acids, except tyrosine (0.5 yig/ml), phenylalanine (0.5 ,ug/ml), and tryptophan (0.1 ,ug/ml). The genotype of small colonies was determined.
Glycerol density gradients. Gradients were as described by Huang et al. (6) except that the gradients were in 0.05 M potassium phosphate buffer, pH 7.0, containing 6 x 10-3 M 2-mercaptoethanol and 6 x 10-4 M pyridoxal phosphate, and they were centrifuged for 36 h.
Diethylaminoethyl-cellulose chromatography. A cell extract containing 25 to 30 mg of protein was applied to a column (0.9 by 12 cm) of DE-52-cellulose equilibrated with 0.05 M potassium phosphate buffer, pH 7.5, containing 0.05 M NaCl and 6 x 10-3 M 2-mercaptoethanol. The proteins were eluted from the column by a linear gradient made from 100 ml of 0.05 potassium phosphate buffer, pH 7.5, 0.05 M NaCl, and 6 x 10-3 M 2-mercaptoethanol and 100 ml of 0.05 M potassium phosphate buffer, pH 7.5, 0.35 M NaCl, and 6 x 10-3 M 2-mercaptoethanol. Fractions of 1.3 ml were collected and assayed for aminotransferase activity.
Chemicals and substrate. All chemicals were obtained from commercial sources as the purest available and were not further purified.
RESULTS
Evidence for two tyrosine and phenylalanine aminotransferase activities. Biochemical evidence. In the course of screening a large number of tyrosine and phenylalanine auxotrophs for their levels of tyrosine and phenylalanine aminotransferase activity, no mutants could be identified that lacked all tyrosine or phenylalanine aminotransferase activity. However, one observation was made consistently. All multiple aromatic amino acid-requiring strains that also contained lesions in the hisH locus, concerned with the synthesis of histidinol phosphate aminotransferase, had approximately 60% less aminotransferase activity for both tyrosine and phenylalanine than did the wild-type strain. Histidine-requiring strains blocked in steps other than histidinol phosphate aminotransferase had the same level of tyrosine and phenylalanine aminotransferase activity as the wild-type strain. The removal of the hisH mutation by either reversion of DNAmediated transformation restored both tyrosine and phenylalanine aminotransferase activities to the wild-type level. The fact that all hisH mutants had a decreased level of tyrosine and phenylalanine aminotransferase activity suggested that histidinol phosphate aminotransferase also plays a role in the transamination reaction in the pathway leading to tyrosine and phenylalanine. Since hisH mutants require only histidine, cells must have at least one additional enzyme capable of forming the amino groups of tyrosine and phenylalanine.
To determine the number of transaminases capable of forming tyrosine and phenylalanine, a crude extract of the wild-type strain was centrifuged through a gradient of glycerol, 10 to 20% (Fig. 1A ). Fractions were collected, and assayed for tyrosine, phenylalanine, and histidinol phosphate aminotransferase activity. The data indicate that there are indeed two enzymes, each capable of forming both tyrosine and phenylalanine. As predicted, one of the enzymes appeared to have an identical molecular weight to the enzyme that forms histidinol phosphate. When a crude extract of a hisH mutant is centrifuged in an identical fashion, one of the two components of aromatic aminotransferase activity remains, but the other disappears together with the histidinol phosphate aminotransferase activity (Fig. 1B) . These data are consistent with the notion that the hisH locus specifies an enzyme that is active in both the histidine and aromatic amino acid biosynthetic pathway.
The same conclusion was reached when crude extracts of the wild-type strain and the hisH mutant were chromatographed separately on DE-52-cellulose ( Fig. 2A and B ). This technique did not separate the two species very well, but there was a strong suggestion that there are two activities of tyrosine and phenylalanine aminotransferase and that one behaves chromatographically identically to the enzyme that forms histidinol phosphate. These data are consistent with the centrifugation results that suggest that the two aminotransferases are active on both tyrosine and phenylalanine.
Genetic evidence. If there are two independent enzymes concerned with the transamination of tyrosine and phenylalanine, it should be possible to isolate mutants that are defective in one or the other or both activities. Strain SF 32, a hisH mutant (3, 15) , represents the class that has lost the species of tyrosine and phenylalanine aminotransferase activity associated with histidinol phosphate aminotransferase (Fig. 1B  and 2B ). We treated this strain with N'-methyl-N'-nitro-N-nitrosoguanidine and plated the survivors on minimal medium supplemented J. BACTERIOL. with histidine, tyrosine, and phenylalanine. Colonies that required tyrosine and phenylalanine were assayed for tyrosine and phenylalanine aminotransferase activity. One mutant was isolated with the following growth characteristics. It did not grow on medium supplemented only with histidine and grew poorly on medium containing histidine and either tyrosine or phenylalanine. It grew normally on medium supplemented with histidine, tyrosine, and phenylalanine. This mutant contained about 1% ofthe wild-type aromatic aminotransferase activity of strain WB746. The second locus controlling aromatic aminotransferase activity is termed aroJ.
This double mutant (hisH-aroJ-) was then transforned with DNA isolated from a prototroph WB746 (13) and transformants were selected on minimal medium supplemented with tyrosine and phenylalanine. These histidineindependent transformants no longer required tyrosine and phenylalanine but still contained the aroJ lesion because although they had regained all of the histidinol phosphate aminotransferase activity of the wild-type strain they only contained 60% of the tyrosine-phenylalanine aminotransferase activity. In addition, the presence of the aroJ lesion was revealed by transformation. DNA from the aroJ mutant strain was added to a hisH-met-auxotroph and the culture was plated on medium containing histidine, tyrosine, and phenylalanine. Approximately 200 met+ colonies were picked to nutrient agar and then replica plated to minimal medium and medium supplemented with tyrosine and phenylalanine. Approximately 1% of the transformants required tyrosine and phenylalanine indicating that the donor DNA still contained the aroJ mutation. Further, the frequency of cotransfer of the tyrosine and phenylalanine requirement with the unlinked methionine locus strongly suggests that the aromatic requirement results from a single lesion and not two genetically unlinked mutations.
The aroJ mutation has no effect on the activity of any of the other enzymes of the aromatic amino acid pathway that have been assayed. These include DAHP synthetase, DHQ synthetase, shikimate kinase, enol pyruvyl shikimate-5-phosphate synthetase, chorismate synthetase, chorismate mutase, prephenate dehydrogenase, and prephenate dehydratase.
When crude extracts ofthe aroJ mutant were centrifuged in a glycerol gradient under identical conditions to that used in the centrifugation of extracts of the wild-type and hisH mutants, it was observed that the heavier species of tyrosine-phenylalanine aminotransferase activity was absent (Fig. 1C) . The phate, tyrosine, and phenylalanine remained.
When a crude extract of the aroJ mutant was chromatographed on diethylaminoethyl-cellulose, one of the two tyrosine and phenylalanine aminotransferase activities disappeared (Fig.  2C) minimal plates, as well as on tyrosine, phenylalanine, and tyrosine plus phenylalanine-supplemented plates. For strain SB32, all plates contained histidine. After incubation for 48 h at 37 C, the size of the colonies was determined. For strain SB32, the sizes of the colonies were the same on all media. However, colonies of strain SB3559 (aroJ) were definitely smaller on tyrosine-supplemented medium than on unsupplemented medium. This probably resulted from the repression of the synthesis of histidinol phosphate aminotransferase by tyrosine (14, 17) . If histidine was added to the tryosinesupplemented plate, the colonies were larger than before but not the size they attained on unsupplemented medium. Most likely this was because the cell still was starved for phenylalanine because tyrosine repressed the only aromatic aminotransferase activity (2, 17) . In support of this interpretation is the observation that the aroJ mutant grew optimally on phenylalanine if tyrosine was not present. From these studies, we conclude that cells lacking one or the other enzyme still have the capacity to synthesize the amounts oftyrosine and phenylalanine required for optimal growth. Obviously, then both aminotransferases do not have to function for aromatic acid synthesis. To determine whether both enzymes actually function in the wild-type cell, we resorted to the use of analogues. Fluorotyrosine and fluorophenylalanine are analogues of tyrosine and phenylalanine, respectively, since their growth-inhibiting properties are overcome by the respective amino acid. The degree of inhibition by each analogue thus serves as a probe for the level of tyrosine or phenylalanine in the' intracellular pool. When fluorotyrosine was placed on a paper disk in the center of a petri plate seeded with either the wild-type aroJ or hisH strain, the zone of inhibition was approximately the same for all three strains. This suggests that the level of tyrosine is about the same in all three strains. However, when a similar experiment was done with fluorophenylalanine, the zones of inhibition were considerably larger with the mutants than with the wild-type strain. This suggests that the level of phenylalanine is lower in the aroJ and hisH mutants than it is in the wild-type strain. The data also suggest that the mutant strains preferentially synthesize tyrosine over phenylalanine.
Regulation of synthesis of the AroJ gene product. Starvation of cells for tyrosine, phenylalanine, or histidine had no effect on the level of the aroJ aminotransferase activity (data not shown). In these experiments three different strains were used, all of which lacked histidinol phosphate aminotransferase activity. To starve cells for histidine, a hisH mutant was grown on 5 ,ug of L-histidine per ml. Mutants which lacked both the hisH gene product as well as prephenate dehydrogenase were starved for tyrosine by growing cells on 5 ,ug of -tyrosine per ml. To starve cells for phenylalanine, a mutant that lacked prephenate dehydratase as well as histidinol phosphate aminotransferase was grown on 5 ,ug of L-phenylalanine per ml. The level of aromatic aminotransferase in regulatory mutants that are derepressed in the synthesis of several enzymes of aromatic acid synthesis (2) is the same as it is in wild-type cells (data not shown). Thus, there is no evidence that any of the aromatic amino acids influences the synthesis of the aroJ gene product.
DISCUSSION
The data in this paper leave little doubt that there are two independent enzyme activities in the cell capable of carrying out the terminal steps in the synthesis of tyrosine and phenylalanine. The most unique feature of this observation is that one of these enzymes is the only aminotransferase that can catalyze the conversion of imidazole acetol phosphate to histidinol phosphate. Thus, a gene of histidine synthesis, hisH, specifies an enzyme catalyzing a reaction in the synthesis of tyrosine and phenylalanine. Since fluorophenylanine is much more inhibitory to hisH mutants than it is to the wild-type strain, we conclude that the histidinol phosphate aminotransferase functions in tyrosine and phenylalanine synthesis in vivo. This inhibitory effect is specific for histidine mutants defective in aminotransferase enzyme activity.
The observation that histidinol phosphate aminotransferase does catalyze the aminotransferase reaction in tyrosine and phenylalanine synthesis caps a search of many years for the molecular bases of the interaction between histidine and aromatic amino acid biosynthesis in B. subtilis. That this particular gene should play a role in aromatic amino acid synthesis is suggested by a number of observations. Firstly, the hisH locus is located in the middle of a cluster of genes, all of which are concerned with aromatic amino acid synthesis (Fig. 3) . Secondly, the expression of the hisH gene is under the combined control of tryptophan and histidine. Thirdly, tyrosine represses the synthesis of the hisH gene product, and histidine represses the synthesis of a contiguous locus, tyrA, prephenate dehydrogenase. Fourthly, single-step mutants have been isolated which are derepressed for the synthesis of most enzymes of histidine and aromatic acid synthesis. In addition, histidine activates the first enzyme of tryptophan synthesis (7, 8) . Apparently the interaction between histidine and aromatic acid synthesis can be manifested in a number of different ways.
These complex regulatory interactions termed cross-pathway regulation, (2, 14) can now be rationalized on a physiological basis. In view of the data presented, the aro linkage group of 13 loci comprises most of the postchorismate as well as two prechorismate enzymes. Thus, it is not surprising that the control of all of these loci would be under the control of aromatic metabolites. On the other hand, since one of the loci also plays an indispensible role in histidine biosynthesis, it is quite logical that this locus also responds to histidine. Thus, the cell seems to have solved this control problem by placing the hisH locus under the combined control of histidine and the aromatic metabolites, tryptophan and tyrosine. Indeed, the observation that single-site mutants can be easily isolated that are derepressed for most enzymes of histidine and aromatic amino acid synthesis can be rationalized on the basis that this locus must respond to the presence of both histidine as well as aromatic metabolites.
The map location and control of the hisH locus favors its being considered an aro gene. However, the fact that there is another functional aromatic aminotransferase but only one for histidine, speaks in favor of its retaining the designation of hisH. In this context, two enzymes capable of forming the amino groups of tyrosine and phenylalanine have been described in Escherichia coli (12) . One of these enzymes also forms aspartate. Based on the Km and Vmax values for the various substrates, these authors concluded that the one capable of catalyzing transamination with aspartate is in fact an aspartate transaminase and not an aromatic acid transaminase. It is important to supplement the present genetic and physiological data with determinations of the Km and Vmax for the various substrates of the histidine and aromatic acid transaminase reaction. Such studies are in progress.
